| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T444 |
0-247 |
Sentence |
denotes |
Fan et al. (2020), China Retrospective/Shanghai Public Health Clinical Center 148/50.5/49.3% females and 50.7% males Laboratory test, RT‐PCR and CT scanning Sera Confirmed SARS‐CoV‐2‐infected patients/a history of related epidemiology Blood: |
| T445 |
248-285 |
Sentence |
denotes |
elevated LDH, AST, ALT, GGT, TB, ALP: |
| T446 |
286-563 |
Sentence |
denotes |
35.1%, 21.6%, 18.2%, 17.6%, 6.1%, 4.1% in all patients; lower CD4+ and CD8+ T cells: (62.67%)/(56.1%) patients with abnormal liver function received more treatment compared with normal liver function (25%) (p = .009) Fever: (70.1%), cough: (45.3%), expectoration at admission: |
| T447 |
564-572 |
Sentence |
denotes |
(26.7%), |
| T448 |
573-611 |
Sentence |
denotes |
Abnormal liver functions at admission: |
| T449 |
612-738 |
Sentence |
denotes |
75 patients (50.7%) with moderate‐high degree fever (44%) in males,/chronic hepatitis B or C: N = 8 5 days (3–7) 1 Therapy: |
| T450 |
739-876 |
Sentence |
denotes |
Antibiotics (Levofloxacin, Meropenem, Moxifloxacin, Cephalosporin), interferon, antiviral drugs (Arbidol, Lopinavir/ritonavir, Dnrunavir) |
| T451 |
877-904 |
Sentence |
denotes |
Results and interpretation: |
| T452 |
905-947 |
Sentence |
denotes |
all patients discharged from the hospital. |
| T453 |
948-1050 |
Sentence |
denotes |
Lopinavir/Ritonavir treatment can significantly alleviate the SARS‐CoV‐2‐induced liver function damage |
